Hikma Pharmaceuticals and Civica Rx have entered a five-year agreement to manufacture and supply Civica’s growing membership of U.S. health systems with medications that are often in short supply in U.S. hospitals.   Hikma will produce 14 essential sterile injectable medications for Civica as a private label distributor, using Hikma’s abbreviated new drug applications (ANDAs) and Civica’s labeling and national drug code (NDC). These medicines are used daily by hospitals in emer...